<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00420810</url>
  </required_header>
  <id_info>
    <org_study_id>0928-049</org_study_id>
    <secondary_id>2006_514</secondary_id>
    <nct_id>NCT00420810</nct_id>
  </id_info>
  <brief_title>Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED)</brief_title>
  <official_title>A Double-Blind, Placebo Controlled, Randomized, Cross-Over Polysomnographic Study of MK0928 15 mg in Adult Patients With Primary Insomnia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>H. Lundbeck A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>H. Lundbeck A/S</source>
  <brief_summary>
    <textblock>
      The purpose of this study is determine whether this drug will improve your insomnia in terms
      of decreasing your time to fall asleep and allowing you to stay asleep longer. The drug will
      be compared against placebo in order to determine if there's a difference.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>September 2006</start_date>
  <primary_completion_date type="Actual">March 2007</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Wake after sleep onset and Latency to persistent sleep</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subjective total sleep time and subjective time to sleep onset</measure>
  </secondary_outcome>
  <enrollment>138</enrollment>
  <condition>Primary Insomnia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>MK0928 / Duration of Treatment : 8 Weeks</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of Primary Insomnia

          -  Patient is willing to stay overnight at a sleep laboratory for a total of 7 nights

          -  Patient is willing to avoid alcohol on PSG visits

          -  Patient will avoid napping during the course of the study

          -  Patient's bedtime is between 9pm and 1am

        Exclusion Criteria:

          -  History of substance abuse, bipolar disorder or psychotic disorder

          -  Difficulty sleeping due to other medical condition

          -  History of narcolepsy, circadian rhythm sleep disorder, parasomnia, sleep apnea,
             periodic limb movements or restless legs syndrome

          -  History of neoplastic malignancy within the last 5 years

          -  Positive alcohol breath test during the screening visits
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Monitor</last_name>
    <role>Study Director</role>
    <affiliation>Merck Sharp &amp; Dohme Corp.</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 5, 2007</study_first_submitted>
  <study_first_submitted_qc>January 10, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2007</study_first_posted>
  <last_update_submitted>January 13, 2015</last_update_submitted>
  <last_update_submitted_qc>January 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2015</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

